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During their development and overall life, mesenchymal stem cells (MSCs) encounter
a plethora of internal and external stress signals and therefore, they need to put in
action homeostatic changes in order to face these stresses. To this aim, similar to
other mammalian cells, MSCs are endowed with two crucial biological responses,
autophagy and senescence. Sharing of a number of stimuli like shrinkage of telomeres,
oncogenic and oxidative stress, and DNA damage, suggest an intriguingly close
relationship between autophagy and senescence. Autophagy is at first reported to
suppress MSC senescence by clearing injured cytoplasmic organelles and impaired
macromolecules, yet recent investigations also showed that autophagy can promote
MSC senescence by inducing the production of senescence-associated secretory
proteins (SASP). These apparently contrary contributions of autophagy may mirror an
intricate image of autophagic regulation on MSC senescence. We here tackle the
pro-senescence and anti-senescence roles of autophagy in MSCs while concentrating
on some possible mechanistic explanations of such an intricate liaison. Clarifying the
autophagy/senescence relationship in MSCs will help the development of more effective
and safer therapeutic strategies.
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INTRODUCTION
Mesenchymal stem cells (MSCs) are the most widely utilized adult stem cells in clinical trials
(Trounson and McDonald, 2015). Thorough investigation has substantiated the capability of MSCs
to differentiate into cells of the mesenchymal lineage including osteoblasts, chondrocytes and
adipocytes, and to secrete several trophic components able to exert their effect at cellular level like
apoptosis and differentiation, at systemic level like immune response modulation and at tissue level
like angiogenesis and fibrosis; further, MSCs sustain cardiac, muscle, and neural tissue regeneration
(da Silva Meirelles et al., 2009; Caplan and Correa, 2011). Cellular senescence and autophagy are
stress responses essential for MSC homeostasis.
Senescence, biologically described as a cellular condition in which cells have lost the proliferative
capacity, yet maintaining their metabolic activity, is a genetically based program responding to
stress signals that avoids damaged cells to further proliferate, acting as a powerful tumor suppressive
Abbreviations: ATG, autophagy-related; LC3, light chain 3; MSC, mesenchymal stem cell; mTOR, mammalian target of
rapamycin; OIS, oncogene induced senescence; ROS, reactive oxygen species; SASP, senescence associated secretory pathway;
TASCC, TOR autophagy spatial coupling compartment.
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mechanism (Kuilman et al., 2010; López-Otín et al., 2013;
Muñoz-Espín and Serrano, 2014; Childs et al., 2015). As
reviewed elsewhere (Turinetto et al., 2016), human MSCs
react with senescence induction in response to various stress
stimuli, including telomere shortening (Baxter et al., 2004),
oxidative stress (Stolzing and Scutt, 2006; Burova et al., 2013;
Kim et al., 2011), heat shock (Alekseenko et al., 2014),
and chemotherapeutic agents (Seifrtova et al., 2013; Minieri
et al., 2015; Skolekova et al., 2016). Besides demonstrating
that senescence program activation is independent of the
MSC tissue source, those previous contributions added several
details in MSC senescence profiles and phenotypes. Specifically,
similar to human fibroblasts (Rodier et al., 2009), human MSC
senescence program was sustained by persistent DNA damage
repair activation, evidenced by the detection of characteristic
enlarged nuclear foci, containing γH2AX and 53BP1 proteins
(Cmielova et al., 2012; Seifrtova et al., 2013; Minieri et al.,
2015; Turinetto and Giachino, 2015). At a molecular level, the
overall network is not yet completely clarified, however, so further
studies are required to better comprehend the mechanisms of
senescence in MSCs.
Macroautophagy (hereafter referred to as autophagy and the
focus of this review) represents a crucial path for the maintenance
of cellular homeostasis under both physiologic and stressful
situations since upon activation it sustains cellular survival
thanks to the preservation of suitable metabolic functions,
bioenergetic levels and amino acid pools. It is a degradation
process of cellular own elements relying on the lysosomal
compartment, representing a fundamental protective answer
to tough situations like nutrient deprivation, where active
recycling of cellular components are needed to guarantee energy
homeostasis (Kang and Avery, 2008; Kroemer et al., 2010; Choi
et al., 2013). In addition to working as a straightforward means
to degrade large molecules that have formed aggregates or
become misfolded, it is implicated in the clearance of altered
and non-functional organelles including mitochondria in order
to maintain appropriate cell metabolism (He and Klionsky,
2009; Boya et al., 2013). The first step of autophagy, the
autophagosome biogenesis, relies on a core machinery consisting
of ATG (autophagy-related) genes and ATG proteins; their
first identification in the yeast (Tsukada and Ohsumi, 1993)
was followed by cloning of their mammalian homologs, that
were found to guarantee similar functions (Mizushima et al.,
2011). A macromolecular complex is involved in autophagosome
nucleation, consisting in the class III phosphatidylinositol
3-kinase and Beclin 1; this complex is also implicated in the
phagophore membrane positioning of several other autophagic
proteins that need to be subsequently recruited (Cao and
Klionsky, 2007). An elongation step at the level of the phagophore
membrane follows; it is performed by two ubiquitin-like
systems, comprising the ATG12–ATG5-ATG16L1 complex and
MAP1LC3/LC3 (microtubule associated protein 1 light chain
3). LC3 molecule is then cleaved to produce cytosolic LC3-
I through the action of ATG4. LC3-I is covalently bound to
phosphatidylethanolamine through the action of ATG7, ATG3
and the ATG12–ATG5-ATG16L1 complex generating LC3-
II. LC3-II represents a very useful indicator of the mature
autophagosome being strictly associated with the phagophore
and autophagosome membrane, so it is largely employed as
a marker of autophagy (Kabeya et al., 2000, 2004). Despite
the fact that autophagy process was first acknowledged as a
non-selective, lysosomal degradation mechanism, referred to
as general autophagy, growing evidence sustains the existence
of a selective autophagy, a form of autophagy mediating the
degradation of specific classes of target molecules.
The intricate relationship between autophagy induced by
diverse extra- or intracellular stimuli and the molecular targets
that influence MSC proliferation, differentiation, and stemness
has been reviewed elsewhere (Guan et al., 2013; Sbrana et al.,
2016). Briefly, in human MSCs, the detection of consistent
LC3-I to LC3-II conversion rates suggests constitutive activation
of the autophagic flux (Oliver et al., 2012; Salemi et al.,
2012) and MSC commitment to various cell lineages relies
on basal autophagy activities, more than anything towards the
osteoblastic lineage. Collection of undegraded autophagosomes
and reduced autophagic turnover in undifferentiated MSCs have
been evidenced, while in contrast stimulation of osteogenic
differentiation resulted in a steady turnover increase (Nuschke
et al., 2014). Conceptually, autophagy and senescence display
common features as both partake in stress cell responses that can
have either cytoprotective or cytotoxic consequences. However,
whether autophagy performs as a positive or negative regulator
of senescence in MSCs is so far debated.
ANTI-SENESCENCE ROLE OF
AUTOPHAGY IN MSCs
The main view of autophagy’s impact is an efficacious anti-
senescence role implicating various pathways, whose principal
players are the (mammalian) target of rapamycin (mTOR),
insulin-like growth factor (IGF) binding to insulin-like growth
factor receptors (IGF1R), adenosine monophosphate-activated
protein kinase (AMPK) and p53 (Rubinsztein et al., 2011).
Indeed, prolonged autophagy impairment in primary human
fibroblasts provided through knocking down ATG7 or ATG5
resulted in cellular senescence, due to mitochondrial impairment
and accumulation of produced reactive oxygen species (ROS)
(Kang et al., 2011). Consistent with this view, increased
autophagic activity was described to be capable of extending
the lifespan of aged mice and elder flies and ripristinating the
self-renewal stem cell activity, providing indications that the anti-
aging effect was at least in part dependent on stem cell function
restoration (Simonsen et al., 2008; Harrison et al., 2009).
More recent investigations have confirmed that autophagy
is requested for sustaining the stemness and differentiation
properties of stem cells. Garcia-Prat et al. described a critical role
for basal autophagy in the maintenance of an immature stage in
satellite cells, and unsuccessful autophagic activity promoted cell
senescence defined by numerical and functional decrease of these
cells (García-Prat et al., 2016).
Along this line, it was found that autophagic activity of
old bone marrow-derived MSCs was diminished in comparison
with young MSCs (Ma et al., 2018). Authors reported that
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autophagy exerted an important function in the maintenance of
MSCs upon aging, and demonstrated that autophagic control
could partly rescue aged MSCs’ features and bone loss in mice
through the regulation of ROS-p53 (Ma et al., 2018). Those
evidence suggested that the autophagic activity of MSCs could
at least in part regulate bone aging, allowing to speculate
the diminished autophagic activity in aged MSCs as one of
the mayor sources of their degenerative modifications, and
bone loss caused by impaired autophagy as an inherent novel
component of bone aging.
The results of premodulated autophagy on MSC senescence
were explored by up- or down-regulating autophagy through
the employment of rapamycin or 3-methyladenine, respectively,
prior to induction of D-galactose-mediated MSC senescence
(Zhang et al., 2020). These studies exemplified that the use of
rapamycin for 24 h reduced MSC senescence significantly in this
experimental setting, and this was accompanied by diminished
ROS production. Downregulation of p-Jun N-terminal kinases
(JNK) and p-38 expression could also be demonstrated in the
rapamycin treated cells (Zhang et al., 2020). In addition, the
protective role of rapamycin on MSC aging could be counteracted
by increasing the level of ROS, and the use of p38 inhibitors could
revert the senescence induction effect of H2O2 on MSCs (Zhang
et al., 2020). Altogether, this study indicated that autophagy
exerted a protecting effect on D-gal-induced MSC senescence,
and ROS/JNK/p38 cascade played a relevant mediating function
in autophagy-mediated delay of MSC senescence. The evidence
that autophagy could protect MSCs from oxidative stress
signaling (Song et al., 2014) represented another indication that
autophagy exerts a preserving function during cell aging. Finally,
in many cases of acute senescence the autophagy flux is seriously
compromised in MSCs, further evidencing that the autophagic
process counterbalances damaging paths, and its negative
modulation favors a senescent state (Capasso et al., 2015).
PRO-SENESCENCE ROLE OF
AUTOPHAGY IN MSCs
Conversely, autophagy markers have been observed in senescent
cells and autophagy has been demonstrated to be necessary for
preservation of replicative senescence of MSCs (Zheng et al.,
2014). Along this line, Zheng et al. showed that autophagy
increased when MSCs entered the replicative aging state, with
p53 contributing a relevant function in the autophagic increment
in this specific setting (Zheng et al., 2016). p53 downregulation
through knockdown experiments resulted in diminished LC3-II
conversion and increased mTOR expression, thus showing that it
represents a crucial trigger for autophagic activation in the course
of in vitro expansion of MSCs (Zheng et al., 2016). Indeed, in
replicative senescent MSCs, up-regulation of autophagy related
genes was detected, however p53 not only played a crucial role in
senescence but was also essential for triggering autophagy during
culture expansion of MSCs (Fafián-Labora et al., 2019).
Further experimental models showed that the senescence
status was somehow dependent on a preliminary autophagy
induction. As an example, diminished insulin-like growth factor
1 (IGF1) expression was found to protect senescent MSCs
kept under conditions of hypoxia by means of an up-regulated
autophagic flux, thus augmenting the survival of senescent MSCs
after myocardial infarction transplantation (Yang et al., 2018).
Also, high glucose levels were reported to induce senescence by
triggering the formation of ROS and upregulating autophagy
in MSCs (Chang et al., 2015). In the above work, MSCs
cultivated in high glucose concentration medium exhibited
premature senescence, as showed by telomeric impact and
genomic instability; it was undoubtedly evidenced that autophagy
upregulation, detected through increased Beclin-1, Atg 5 and 7
expression, and augmented LC3-II conversion rate, correlated
with senescence induction in MSCs while, on the opposite,
negative regulation of autophagy employing 3-methyladenine
prevented cellular degeneration (Chang et al., 2015).
Lastly, a few reports described oncogene-induced senescence
(OIS) in MSCs in conjunction with disease manifestation.
In patients suffering from systemic lupus erythematosus,
for example, leptin and Neutrophil-Activating Peptide 2
sustained MSC senescence through activation of the PI3K/AKT
signaling (Chen et al., 2015). Another oncogene, ASPL-
TFE3, was demonstrated to induce MSC senescence through
p21 up-regulation in alveolar soft part sarcoma (Ishiguro
and Yoshida, 2016). In this type of induced senescence,
Young et al. reported for the first time in fibroblast cells
a causal association between autophagy and senescence,
demonstrating that autophagy was activated during OIS and,
in particular, it regulated the SASP at a post-transcriptional
level, leading to the interesting speculation that autophagy
provided the building blocks for the SASP protein production
(Young et al., 2009). When a specialized type of general
autophagy known as the TOR autophagy spatial coupling
compartment or TASCC was later identified to be responsible
for the protein synthesis of some SASP factors, previous
speculation could be corroborated (Narita et al., 2011). The
field, however, awaits further research to assess whether
in MSCs similar pro-senescence autophagic activities take
place during OIS.
RECONCILIATION
From these previous data, it appears that autophagy acts in MSCs
as either a pro-senescence or an anti-senescence process, thus
if and in what manner autophagy directs MSC aging remains
elusive (Table 1).
Although the molecular bases underpinning senescence,
particularly those overlapping with autophagy, are yet poorly
comprehended, reconciling these antithetic phenomena would
be feasible only by speculating that autophagy may regulate
a number of targets oppositely acting to modulate cellular
senescence in MSCs. Interestingly, recent studies disclosed
distinct functions of general versus selective autophagy in the
control of senescence, partially solving seemingly conflicting
evidence concerning the relation between these two fundamental
homeostatic responses to stress stimuli. In model cells other
than MSCs, Kwon et al. suggested the interesting possibility that
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TABLE 1 | Types of autophagy and their effect on senescence in MSCs and other cell types.
Cellular model Type of autophagy Effect on senescence Senescence stimulus References
MSC General Anti-senescence Replicative exhaustion Ma et al., 2018
MSC General Anti-senescence D-galactose Zhang et al., 2020
MSC General Anti-senescence Oxidative stress Song et al., 2014




MSC General Pro-senescence Replicative exhaustion Zheng et al., 2014
MSC General Pro-senescence Replicative exhaustion Zheng et al., 2016
MSC General Pro-senescence Replicative exhaustion Fafián-Labora et al., 2019
MSC General Pro-senescence Hypoxia Yang et al., 2018
MSC General Pro-senescence Glucose Chang et al., 2015
MSC Selective Anti-senescence Lamin accumulation Lee et al., 2018
MSC Selective Pro-senescence Lamin accumulation Infante et al., 2014
Fibroblast Selective Anti-senescence OIS Kang et al., 2015
Fibroblast General (TASCC) Pro-senescence OIS Narita et al., 2011
Lung primary cell Selective Pro-senescence OIS Dou et al., 2015
such a dual role might be context and time dependent as well
as specifically depend on the type of autophagy, general versus
selective, involved (Kwon et al., 2017).
According to this model, under normal conditions, general
autophagy would act as an anti-senescence process by preserving
cellular homeostasis. Upon situations of induced stress, early
action of general autophagy would also play the role of a
homeostatic response, thus prevalently anti-senescent (with the
exception of some specialized types of general autophagy like
the TASCC). However, general autophagy exerted in cells that
have already initiated a senescence process can become pro-
senescent, in the sense that it can sustain viability of senescent
cells. Indeed, senescent cells cannot dilute toxic byproducts
as they do not undergo mitosis and they secrete a number
of factors that can induce endoplasmic reticulum stress; in
these conditions, autophagy induction could counteract the
risk of proteostasis disruption and avoid cell death (Kwon
et al., 2017). Accordingly, the anti-senescence autophagy roles
reported above for MSCs were mainly related to general
autophagy, and autophagy manipulation experiments were
conducted before senescence induction. Conversely, the pro-
senescence roles of general autophagy described in MSCs
referred to either long-term cultured cells, with a presumably
already initiated senescence pathway, or, possibly, to oncogene-
induced senescence.
In the case of selective autophagy, when only a certain
type of substrates is degraded, the resulting role on senescence
would depend on the specific substrates and autophagic receptors
involved. While looking for regulators of cellular senescence,
Kang and Elledge (2016) identified GATA4 as a crucial regulator
of the SASP and senescence. GATA4 is a transcription factor
whose protein stability increases during cellular senescence
leading to its accumulation. Intriguingly, authors showed a
clear autophagic regulation of GATA4: under normal conditions,
it is degraded thanks to the autophagic receptor protein
SQSTM1/p62, yet when the cell encounters senescence-inducing
stimuli, a steady decrease of the interaction between GATA4
and SQSTM1/p62 occurs, autophagic degradation is limited
and GATA4 accumulates (Kang and Elledge, 2016). This
accumulated GATA4 starts a transcriptional activity to switch
on NFKB/NF-kB and in turn the SASP. Interestingly, GATA4-
dependent regulation of the secretory phenotype was recently
found to play an important role in human MSC aging (Lee et al.,
2018). On the other hand, LC3B-lamin B1-dependent selective
autophagy of nuclear lamina was found to act as a pro-senescence
mechanism (Dou et al., 2015). Interestingly, a model of human
aging based on MSCs with accumulated prelamin has been
proposed (Infante et al., 2014). Taken altogether, these data seem
to suggest that selective autophagy actively suppresses cellular
senescence through the degradation of a senescence regulator,
GATA4, whereas it promotes cellular senescence through the
degradation of nuclear lamina and open the way for a similar dual
control of autophagy over senescence also in MSCs.
So at least three elements, i.e., the context, time of action
and type of autophagy involved appear to constitute the frame
in which autophagy can result either pro or anti-senescence in
MSCs, as depicted in Figure 1. However, a few intriguing open
questions concerning the extent to which cell-specific features,
such as cell origin, metabolic status and age might contribute the
final effect will deserve further investigation.
CLINICAL IMPLICATIONS
When tissue homeostasis is disrupted due to MSC senescence
the possible shortcoming is twofold: a loss of repairing capability
caused by decreased self-renewal/differentiation abilities and a
detrimental microenvironment modulation by senescent MSCs
due to secretion of pro-inflammatory and matrix-degrading
molecules contained in the SASP. Both have important clinical
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FIGURE 1 | Type of autophagy, time of action and context as the frame to explain the dual role of autophagy in MSC senescence. (A) General autophagy, under
normal conditions and when exerting early action in stressed cells, is mainly anti-senescence as it maintains cellular homeostasis; however, in late stressed and
long-term cultured MSCs (pro-senescent cells) autophagy becomes pro-senescence as it can manage several senescence-associated stresses maintaining
senescent cell viability; it is also possible that, under OIS, a specialized form of general autophagy known as TASCC might occur in MSCs. (B) Selective autophagy is
pro or anti-senescence depending on the specific substrates and context involved: in normal conditions, p62-dependent autophagy specifically degrades GATA4, a
main regulator of the SASP, thus actively suppressing cellular senescence, yet when the cell encounters senescence-inducing stimuli, a steady decrease of the
interaction between GATA4 and p62 occurs and accumulated GATA4 transcriptionally activates the SASP; on the other hand, LC3B-lamin B1-dependent selective
autophagy of nuclear lamina acts as a pro-senescence mechanism.
implications, so clarifying the autophagy/senescence relationship
in MSCs might have an impact for the development of more
effective and safer therapeutic strategies.
As an example, the regulation of autophagy in MSCs
exemplifies a conceivable strategy which, influencing MSC
characteristics, may hit their regenerative potential, both in terms
of differentiation properties and engraftment ability (Ceccariglia
et al., 2020). Activation of autophagy promoted osteogenesis in
bone marrow-derived MSCs isolated from osteoporotic vertebrae
(Wan et al., 2017) and prevented bone loss in elderly mice,
suggesting that autophagy has a crucial role in the aging of
MSCs; in this setting, autophagy upregulation could partly
revert this senescence process exemplifying a likely therapeutic
strategy for clinically treating age-related bone loss (Ma et al.,
2018). Further, evidence indicated that modulation of autophagy
in MSCs prior to their transplantation enhanced survival
and viability of engrafted MSCs and promoted their pro-
angiogenic and immunomodulatory characteristics (Jakovljevic
et al., 2018). Some organic molecules and metabolites showed a
role in autophagy/senescence modulation: cholesterol retarded
senescence in bone marrow-derived MSCs by modulating
autophagy (Zhang et al., 2016) while kynurenine inhibited
autophagy and promoted senescence in aged bone marrow-
derived MSCs through the aryl hydrocarbon receptor pathway
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(Kondrikov et al., 2020) which might represent a novel target
to prevent or reduce age-associated bone loss and osteoporosis.
Lately, to promote the efficiency of MSCs for clinical therapies,
not only the intrinsic aging of these cells in vivo but also
their aging in vitro upon culture expansion poses a tangible
burden and should be counteracted. Among possible druggable
pathways, autophagy manipulation during MSC expansion has
been proposed through the employment of FDA-approved drugs
like rapamycin and its derivatives (Rossi et al., 2019), which
might help assessing the possibility of pharmacological extension
of maximal cell lifespan while simultaneously enhancing MSC
regulatory properties; further, novel small molecules known to
selectively sense and react to acidic pH with high sensitivity
were proved capable of promoting lysosomal acidification and
inhibiting senescence in cultured MSCs through autophagy
induction (Wang et al., 2018).
These and future studies on relevant targets and small
molecules leading to the control and maintenance of optimal
levels of autophagy might open up the way to new strategies for
improving MSC transplantation.
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